Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery.
BACKGROUND
Hepatic ischaemia-reperfusion (I/R) injury occurs in both liver resectional surgery and in transplantation. The biochemistry of I/R injury involves short-lived oxygen free radicals. N-acetylcysteine (NAC) is a thiol-containing synthetic compound used in the treatment of acetaminophen toxicity. The present study is a detailed overview of the experimental and clinical evidence for the use of NAC as a pharmaco-protection agent in patients undergoing major liver surgery or transplantation.


METHODS
A computerized search of the Medline, Embase and SCI databases for the period from 1st January 1988 to 31st December 2008 produced 40 reports. For clinical studies, the quality of reports was assessed according to the criteria reported by the Cochrane communication review group.


RESULTS
Nineteen studies evaluated NAC in experimental liver I/R injury. NAC was administered before induction of ischaemia in 13. The most widely used concentration was 150 mg/kg by intravenous bolus. Fifteen studies report an improvement in outcome, predominantly a reduction in transaminase. Seven studies used an isolated perfused liver model with all showing improvement (predominantly an improvement in bile production after N-acetylcysteine). Two out of four transplantation models showed an improvement in hepatic function. Clinical studies in transplantation show a modest improvement in transaminase levels with no beneficial effect on either patient or graft survival.


CONCLUSIONS
N-acetylcysteine, given before induction of a liver I/R injury in an experimental model can ameliorate liver injury. Clinical outcome data are limited and there is currently little evidence to justify use either in liver transplantation or in liver resectional surgery.
Hepatobiliary Surgery Unit, Department of Surgery, Manchester Royal infirmary, Manchester, UK.
Santhalingam
S
Jegatheeswaran
Ajith K
AK
Siriwardena
D000111:Acetylcysteine / Q000008:administration & dosage*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D004195:Disease Models, Animal; D019317:Evidence-Based Medicine; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D018384:Oxidative Stress / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism; D015427:Reperfusion Injury / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D016896:Treatment Outcome
D000975:Antioxidants; D017382:Reactive Oxygen Species; D000111:Acetylcysteine
Transplant Proc. 1998 Nov;30(7):3763
9838648
Br J Surg. 2004 Oct;91(10):1330-9
15376207
Ann Hepatol. 2005 Apr-Jun;4(2):121-6
16010245
Am J Surg. 2001 Feb;181(2):160-6
11425059
Transpl Int. 1998;11 Suppl 1:S390-2
9665023
Transplantation. 1996 May 15;61(9):1397-402
8629304
Transplantation. 1999 Aug 15;68(3):327-30
10459534
Br J Anaesth. 1995 Sep;75(3):352-4
7547057
Pediatr Transplant. 2001 Aug;5(4):274-8
11472606
Eur Surg Res. 1996 Jul-Aug;28(4):270-7
8813651
Exp Toxicol Pathol. 2003 Jun;54(5-6):423-31
12877355
Transplant Proc. 2005 Dec;37(10):4547-9
16387166
Eur J Surg. 1998 Feb;164(2):139-46
9537722
Biochem Biophys Res Commun. 1999 Aug 11;261(3):917-22
10441525
Clin Exp Med. 2008 Dec;8(4):193-8
18810589
Eur Surg Res. 2008;41(2):226-30
18520151
Transplant Proc. 1999 Sep;31(6):2439-40
10500661
Eur Surg Res. 1996 Jul-Aug;28(4):245-55
8813648
Hepatogastroenterology. 2006 Jul-Aug;53(70):576-9
16995465
Transplantation. 1994 Apr 27;57(8):1161-8
8178341
J Surg Res. 2005 Aug;127(2):164-70
16083753
Transplantation. 2001 Aug 27;72(4):694-8
11544433
J Surg Res. 2005 Nov;129(1):31-7
16140340
Transplant Proc. 1997 Dec;29(8):3347-9
9414743
Anaesth Intensive Care. 2003 Jun;31(3):267-71
12879670
Life Sci. 2003 May 2;72(24):2707-18
12679188
J Hepatol. 2003 Dec;39(6):972-7
14642614
BMJ. 1991 Oct 26;303(6809):1026-9
1954453
Nephrol Dial Transplant. 2010 Jul;25(7):2328-33
20179007
Free Radic Biol Med. 2007 Mar 15;42(6):882-92
17320770
Transplant Proc. 2005 Jan-Feb;37(1):425-7
15808665
Cell Mol Life Sci. 2003 Jan;60(1):6-20
12613655
Transpl Int. 1995;8(4):317-23
7546156
Lancet. 1977 Aug 27;2(8035):432-4
70646
Br Med J. 1980 Jan 5;280(6206):46-7
7357268
ANZ J Surg. 2007 Mar;77(3):173-6
17305994
Transplant Proc. 1993 Apr;25(2):1983-4
8470253
Clin Exp Immunol. 2001 May;124(2):337-41
11422213
Transplantation. 1995 Jan 15;59(1):6-9
7839430
FASEB J. 1997 Feb;11(2):118-24
9039953
Microsurgery. 2007;27(4):295-9
17477423
Clin Sci (Lond). 2005 Nov;109(5):465-73
15982189
Clin Chim Acta. 1998 Jul 28;275(2):127-35
9721071
Hepatobiliary Pancreat Dis Int. 2007 Jun;6(3):284-9
17548252
Hepatology. 1997 Sep;26(3):670-8
9303498
Transplant Proc. 2008 Nov;40(9):2978-80
19010165
J Pharmacol Exp Ther. 2001 Jan;296(1):1-6
11123355
Gastroenterology. 1995 Dec;109(6):1907-16
7498656
Liver Transpl Surg. 1998 Mar;4(2):152-7
9516568
Physiol Rev. 1994 Jan;74(1):139-62
8295932
Hepatology. 1995 Aug;22(2):539-45
7635422